Fundamental dimension Equity attribute | CSRVFLeader $0.37310.00% Cap $3.58MP/E -162.5x QuantScore29/100 | CBBLFPeer $0.080.00% Cap $6.17MP/E -29.4x QuantScore28/100 | GBBGFPeer $0.00730.00% Cap $767.5KP/E -4.2x QuantScore12/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
64/100 |
53/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 23/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 25/100 | 20/100 |
Growth Revenue / earnings growth & margins | 0/100 | 0/100 | 7/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -162.5x | -29.4x | -4.2x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -23.1x | -67.2x | -5.1x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -18.6x | -483.3x | -6.4x |
PEG ratio | 1.46 | 0.16 | -0.35 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | 0.38 (Distress) | -75.72 (Distress) | -4.92 (Distress) |
Total debt / equity | 0.00 | -0.07 | 0.11 |
Quick ratio | 0.1x | 0.2x | 0.1x |
Interest coverage | — | — | -9.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | -199.0% | -730.1% | -1.1% |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | +44.0% | 0.0% | -41.4% |
3M return | +31.4% | +83.1% | -52.9% |
6M return | +31.4% | +153.2% | -45.1% |
Year to date | +26.9% | +247.8% | +4.3% |
1Y return | +122.1% | +6566.7% | -17.0% |
3Y return | +24.4% | +700.0% | -57.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.0346 -90.7% premium | $-0.0008 -101.0% premium | $-0.0031 -142.4% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |